Clinical trial
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological…
NCT00438776 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00438776 |
|---|---|
| Title | Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | Eli Lilly and Company Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pathological Gambling |
| Intervention type | Drug |
| Interventions | olanzapine, sugar pill |
| Enrollment | 42 |
| Start date | Feb 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Feb 22, 2007 |
| Last update posted | Dec 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: